Effect and Safety of Helicobacter pylori Eradication Treatment Based on Molecular Pathologic Antibiotic Resistance in Chinese Elderly People

References

• Liu WZ, Xie Y, Lu H, et al. Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection. Helicobacter. 2018;23(2):e12475. doi:10.1111/hel.12475
   PubMed Web of Science ®Google Scholar
• Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353–1367. doi:10.1136/gutjnl-2015-309252
   PubMed Web of Science ®Google Scholar
• Cho J, Prashar A, Jones NL, Moss SF. Helicobacter pylori infection. Gastroenterol Clin North Am. 2021;50(2):261–282. doi:10.1016/j.gtc.2021.02.001
   PubMed Web of Science ®Google Scholar
• Jessurun J. Helicobacter pylori: an evolutionary perspective. Histopathology. 2021;78(1):39–47. doi:10.1111/his.14245
   Web of Science ®Google Scholar
• Sanaei MJ, Shirzad H, Soltani A, et al. Up-regulated CCL18, CCL28 and CXCL13 expression is associated with the risk of gastritis and peptic ulcer disease in Helicobacter pylori infection. Am J Med Sci. 2021;361(1):43–54. doi:10.1016/j.amjms.2020.07.030
   Web of Science ®Google Scholar
• Della Bella C, Soluri MF, Puccio S, et al. The Helicobacter pylori CagY protein drives gastric Th1 and Th17 inflammation and B cell proliferation in gastric MALT lymphoma. Int J Mol Sci. 2021;22(17):9459. doi:10.3390/ijms22179459
   Web of Science ®Google Scholar
• Ford AC, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis. Gut. 2020;69(12):2113–2121. doi:10.1136/gutjnl-2020-320839
   PubMed Web of Science ®Google Scholar
• Graham DY, Megraud F. Classification system for Helicobacter pylori therapies: compared and contrasted to traditional infectious disease therapy. Helicobacter. 2021;26(1):e12773. doi:10.1111/hel.12773
   Web of Science ®Google Scholar
• Gong EJ, Ahn JY, Kim JM, et al. Genotypic and phenotypic resistance to clarithromycin in Helicobacter pylori strains. J Clin Med. 2020;9(6):1930. doi:10.3390/jcm9061930
   Web of Science ®Google Scholar
• Gong M, Han Y, Wang X, et al. Effect of temperature on metronidazole resistance in Helicobacter pylori. Front Microbiol. 2021;12:681911. doi:10.3389/fmicb.2021.681911
   Web of Science ®Google Scholar
• Jiang ZD, He BS, Zhang ZY, Wang SK, Ran D, Wang ZB. Analysis of the primary and post-treatment antibiotic resistance of Helicobacter pylori in the Nanjing area. Curr Pharm Biotechnol. 2021;22(5):682–685. doi:10.2174/1389201021666200722162613
   Web of Science ®Google Scholar
• Liou JM, Malfertheiner P, Lee YC, et al. Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut. 2020;69(12):2093–2112. doi:10.1136/gutjnl-2020-322368
   PubMed Web of Science ®Google Scholar
• Ding SZ, Du YQ, Lu H, et al. Chinese consensus report on family-based Helicobacter pylori infection control and management (2021 Edition). Gut. 2022;71(2):238–253. doi:10.1136/gutjnl-2021-325630
   PubMed Web of Science ®Google Scholar
• Gao C, Du SY, Fang L, Fan YH, Song AP, Chen H. Eradication treatment of Helicobacter pylori infection based on molecular pathologic antibiotic resistance. Infect Drug Resist. 2020;13:69–79. doi:10.2147/IDR.S232169
   Web of Science ®Google Scholar
• Albasha AM, Elnosh MM, Osman EH, et al. Helicobacter pylori 23S rRNA gene A2142G, A2143G, T2182C, and C2195T mutations associated with clarithromycin resistance detected in Sudanese patients. BMC Microbiol. 2021;21(1):38. doi:10.1186/s12866-021-02096-3
   Web of Science ®Google Scholar
• Haumaier F, Schneider-Fuchs A, Backert S, Vieth M, Sterlacci W, Wöhrl BM. Rapid detection of quinolone resistance mutations in gyrA of Helicobacter pylori by real-time PCR. Pathogens. 2022;11(1):59. doi:10.3390/pathogens11010059
   Web of Science ®Google Scholar
• Gantuya B, El Serag HB, Saruuljavkhlan B, et al. Advantage of 16S rRNA amplicon sequencing in Helicobacter pylori diagnosis. Helicobacter. 2021;26(3):e12790. doi:10.1111/hel.12790
   PubMed Web of Science ®Google Scholar
• Peng C, Hu Y, Ge ZM, Zou QM, Lyu NH. Diagnosis and treatment of Helicobacter pylori infections in children and elderly populations. Chronic Dis Transl Med. 2020;5(4):243–251. doi:10.1016/j.cdtm.2019.12.003
   Google Scholar
• Ji CR, Liu J, Li YY, et al. Safety of furazolidone-containing regimen in Helicobacter pylori infection: a systematic review and meta-analysis. BMJ Open. 2020;10(10):e037375. doi:10.1136/bmjopen-2020-037375
   Web of Science ®Google Scholar
• Wang J, Cao Y, He W, Li X. Efficacy and safety of bismuth quadruple regimens containing tetracycline or furazolidone for initial eradication of Helicobacter pylori. Medicine. 2021;100(51):e28323. doi:10.1097/MD.0000000000028323
   PubMed Web of Science ®Google Scholar
• Boyanova L, Gergova G, Markovska R, et al. Primary Helicobacter pylori resistance in elderly patients over 20 years: a Bulgarian study. Diagn Microbiol Infect Dis. 2017;88(3):264–267. doi:10.1016/j.diagmicrobio.2017.05.001
   Web of Science ®Google Scholar
• Safe AF, Warren B, Corfield A, et al. Role of serology in monitoring treatment for Helicobacter pylori infection in elderly patients. Age Ageing. 1993;22(4):256–259. doi:10.1093/ageing/22.4.256
   Web of Science ®Google Scholar
• Pilotto A, Franceschi M, Leandro G, et al. The clinical usefulness of serum pepsinogens, specific IgG anti-HP antibodies and gastrin for monitoring Helicobacter pylori treatment in older people. J Am Geriatr Soc. 1996;44(6):665–670. doi:10.1111/j.1532-5415.1996.tb01829.x
   Web of Science ®Google Scholar
• Pilotto A, Di Mario F, Franceschi M, et al. Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers. Aliment Pharmacol Ther. 1996;10(6):1021–1027. doi:10.1046/j.1365-2036.1996.88260000.x
   Web of Science ®Google Scholar
• Durazzo M, Ferro A, Fagoonee S, Staiano MT, Saracco GM, Pellicano R. Helicobacter pylori eradication with a clarithromycin-based triple therapy in elderly patients. Panminerva Med. 2021;63(3):332–335. doi:10.23736/S0031-0808.21.04500-6
   Web of Science ®Google Scholar
• Kobayashi S, Joshita S, Yamamoto C, et al. Efficacy and safety of eradication therapy for elderly patients with Helicobacter pylori infection. Medicine. 2019;98(30):e16619. doi:10.1097/MD.0000000000016619
   PubMed Web of Science ®Google Scholar